James Oliviero
Amministratore Delegato presso CHECKPOINT THERAPEUTICS, INC.
Patrimonio netto: 4 M $ in data 31/05/2024
Profilo
James F.
Oliviero is currently the President, Chief Executive Officer & Director at Checkpoint Therapeutics, Inc. He is also an Independent Director at Nuvectis Pharma, Inc. Previously, he served as the Finance Director at ACCESS Oncology, Inc. from 1999 to 2003.
He then worked as the Chief Financial Officer & Treasurer at Keryx Biopharmaceuticals, Inc. from 2003 to 2015.
Mr. Oliviero completed his undergraduate degree at Goizueta Business School-Emory.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 26/06/2024 | 1 939 280 ( 5.36% ) | 4 M $ | 31/05/2024 | |
NUVECTIS PHARMA, INC.
0.32% | 13/06/2024 | 57 828 ( 0.32% ) | 391 496 $ | 31/05/2024 |
Posizioni attive di James Oliviero
| Società | Posizione | Inizio |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Amministratore Delegato | 13/10/2015 |
| NUVECTIS PHARMA, INC. | Direttore/Membro del Consiglio | 01/07/2021 |
Precedenti posizioni note di James Oliviero
| Società | Posizione | Fine |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Direttore Finanziario/CFO | 01/09/2015 |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Direttore Finanziario/CFO | 01/05/2003 |
Formazione di James Oliviero
| Goizueta Business School-Emory | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Health Technology |
| NUVECTIS PHARMA, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Health Technology |
- Borsa valori
- Insiders
- James Oliviero
